Controlling the fate of NIK: A central stage in noncanonical NF-κB signaling

Science Signaling

Volumn 3, Issue 123, 2010, Pages

  Sun, Shao Cong ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NUCLEAR FACTOR KAPPA B INDUCING KINASE; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG;

ENZYME DEGRADATION; ENZYME PHOSPHORYLATION; FEEDBACK SYSTEM; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; FEEDBACK, PHYSIOLOGICAL; HUMANS; I-KAPPA B KINASE; MODELS, BIOLOGICAL; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION;

EID: 77953835976     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.3123pe18     Document Type: Review

References (32)

1. M. S. Hayden, S. Ghosh, Shared principles in NFkappaB signaling. Cell 132, 344-362 (2008).
2. S. Vallabhapurapu, M. Karin, Regulation and function of NF-kappaB transcription factors in the immune system. Annu. Rev. Immunol. 27, 693-733 (2009).
3. K. D. Brown, E. Claudio, U. Siebenlist, The roles of the classical and alternative nuclear factorkappaB pathways: Potential implications for autoimmunity and rheumatoid arthritis. Arthritis Res. Ther. 10, 212 (2008).
4. M. Karin, NF-kappaB as a critical link between inflammation and cancer. Cold Spring Harb. Perspect. Biol. 1, a000141 (2009).
5. M. Pasparakis, Regulation of tissue homeostasis by NF-kappaB signalling: Implications for inflammatory diseases. Nat. Rev. Immunol. 9, 778-788 (2009).
6. S. C. Sun, S. C. Ley, New insights into NF-kappaB regulation and function. Trends Immunol. 29, 469-478 (2008).
7. B. Razani, B. Zarnegar, A. J. Ytterberg, T. Shiba, P. W. Dempsey, C. F. Ware, J. A. Loo, G. Cheng, Negative feedback in noncanonical NF-κB signaling modulates NIK stability through IKKα-mediated phosphorylation. Sci. Sig. 3, ra41 (2010).
8. S. Beinke, S. C. Ley, Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. Biochem. J. 382, 393-409 (2004).
9. E. Dejardin, The alternative NF-kappaB pathway from biochemistry to biology: Pitfalls and promises for future drug development. Biochem. Pharmacol. 72, 1161-1179 (2006).
10. G. Xiao, E. W. Harhaj, S. C. Sun, NF-kappaBinducing kinase regulates the processing of NF-kappaB2 p100. Mol. Cell 7, 401-409 (2001).
11. U. Senftleben, Y. Cao, G. Xiao, F. R. Greten, G. Krähn, G. Bonizzi, Y. Chen, Y. Hu, A. Fong, S. C. Sun, M. Karin, Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 293, 1495-1499 (2001).
12. L. Ling, Z. Cao, D. V. Goeddel NF-kappaB-inducing kinase activates IKK-alpha by phosphorylation of Ser-176. Proc. Natl. Acad. Sci. U. S. A. 95, 3792-3797 (1998).
13. G. Xiao, A. Fong, S. C. Sun, Induction of p100 processing by NF-kappaB-inducing kinase involves docking IkappaB kinase alpha (IKKalpha) to p100 and IKKalpha-mediated phosphorylation. J. Biol. Chem. 279, 30099-30105 (2004).
14. G. Liao, M. Zhang, E. W. Harhaj, S. C. Sun, Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation. J. Biol. Chem. 279, 26243-26250 (2004).
15. E. Claudio, K. Brown, S. Park, H. Wang, U. Siebenlist, BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat. Immunol. 3, 958-965 (2002).
16. C. Liang, M. Zhang, S. C. Sun, beta-TrCP binding and processing of NF-kappaB2/p100 involve its phosphorylation at serines 866 and 870. Cell. Signal. 18, 1309-1317 (2006).
17. J. Q. He, B. Zarnegar, G. Oganesyan, S. K. Saha, S. Yamazaki, S. E. Doyle, P. W. Dempsey, G. Cheng, Rescue of TRAF3-null mice by p100 NFkappa B deficiency. J. Exp. Med. 203, 2413-2418 (2006).
18. E. Varfolomeev, J. W. Blankenship, S. M. Wayson, A. V. Fedorova, N. Kayagaki, P. Garg, K. Zobel, J. N. Dynek, L. O. Elliott, H. J. Wallweber, J. A. Flygare, W. J. Fairbrother, K. Deshayes, V. M. Dixit, D. Vucic, IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNF alphadependent apoptosis. Cell 131, 669-681 (2007).
19. J. E. Vince, W. W. Wong, N. Khan, R. Feltham, D. Chau, A. U. Ahmed, C. A. Benetatos, S. K. Chunduru, S. M. Condon, M. McKinlay, R. Brink, M. Leverkus, V. Tergaonkar, P. Schneider, B. A. Callus, F. Koentgen, D. L. Vaux, J. Silke, IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell 131, 682-693 (2007).
20. S. Vallabhapurapu, A. Matsuzawa, W. Zhang, P. H. Tseng, J. J. Keats, H. Wang, D. A. Vignali, P. L. Bergsagel, M. Karin, Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling. Nat. Immunol. 9, 1364-1370 (2008).
21. B. J. Zarnegar, Y. Wang, D. J. Mahoney, P. W. Dempsey, H. H. Cheung, J. He, T. Shiba, X. Yang, W. C. Yeh, T. W. Mak, R. G. Korneluk, G. Cheng, Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat. Immunol. 9, 1371-1378 (2008).
22. P. Xie, L. L. Stunz, K. D. Larison, B. Yang, G. A. Bishop, Tumor necrosis factor receptor-associated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organs. Immunity 27, 253-267 (2007).
23. S. Gardam, F. Sierro, A. Basten, F. Mackay, R. Brink, TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor. Immunity 28, 391-401 (2008).
24. C. M. Annunziata, R. E. Davis, Y. Demchenko, W. Bellamy, A. Gabrea, F. Zhan, G. Lenz, I. Hanamura, G. Wright, W. Xiao, S. Dave, E. M. Hurt, B. Tan, H. Zhao, O. Stephens, M. Santra, D. R. Williams, L. Dang, B. Barlogie, J. D. J. Shaughnessy Jr., W. M. Kuehl, L. M. Staudt, Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell 12, 115-130 (2007).
25. J. J. Keats, R. Fonseca, M. Chesi, R. Schop, A. Baker, W. J. Chng, S. Van Wier, R. Tiedemann, C. X. Shi, M. Sebag, E. Braggio, T. Henry, Y. X. Zhu, H. Fogle, T. Price-Troska, G. Ahmann, C. Mancini, L. A. Brents, S. Kumar, P. Greipp, A. Dispenzieri, B. Bryant, G. Mulligan, L. Bruhn, M. Barrett, R. Valdez, J. Trent, A. K. Stewart, J. Carpten, P. L. Bergsagel, Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Cancer Cell 12, 131-144 (2007).
26. A. Matsushima, T. Kaisho, P. D. Rennert, H. Nakano, K. Kurosawa, D. Uchida, K. Takeda, S. Akira, M. Matsumoto, Essential role of nuclear factor (NF)-kappaB-inducing kinase and inhibitor of kappaB (IkappaB) kinase alpha in NF-kappaB activation through lymphotoxin beta receptor, but not through tumor necrosis factor receptor I. J. Exp. Med. 193, 631-636 (2001).
27. N. L. Malinin, M. P. Boldin, A. V. Kovalenko, D. Wallach, MAP3K-related kinase involved in NFkappaB induction by TNF, CD95 and IL-1. Nature 385, 540-544 (1997).
28. B. Zarnegar, S. Yamazaki, J. Q. He, G. Cheng, Control of canonical NF-kappaB activation through the NIK-IKK complex pathway. Proc. Natl. Acad. Sci. U. S. A. 105, 3503-3508 (2008).
29. T. Lawrence, M. Bebien, G. Y. Liu, V. Nizet, M. Karin, IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation. Nature 434, 1138-1143 (2005).
30. Q. Li, Q. Lu, V. Bottero, G. Estepa, L. Morrison, F. Mercurio, I. M. Verma, Enhanced NF-kappaB activation and cellular function in macrophages lacking IkappaB kinase 1 (IKK1). Proc. Natl. Acad. Sci. U. S. A. 102, 12425-12430 (2005).
31. X. Lin, Y. Mu, E. T. J. Cunningham Jr., K. B. Marcu, R. Geleziunas, W. C. Greene, Molecular determinants of NF-kappaB-inducing kinase action. Mol. Cell. Biol. 18, 5899-5907 (1998).
32. Funding: Work performed in the author's laboratory is supported by NIH grants AI064639, AI057555, and GM084459.